Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Market Size of the Hypercalcemia Treatment Market In 2029?
Over the past few years, there has been a swift surge in the market size of hypercalcemia treatment. The market, which is expected to rise from $16.44 billion in 2024 to $18.29 billion in 2025, is predicted to have a compound annual growth rate (CAGR) of 11.2%. Factors such as growing awareness about hypercalcemia, an increase in the elderly population, a rise in cancer incidences, enhanced disease comprehension, and a surge in parathyroid disorders prevalence have contributed to the growth seen in the historical period.
The market for hypercalcemia treatment is predicted to experience swift expansion in the upcoming years, increasing to a value of$28.08 billion in 2029″ with a compound annual growth rate of 11.3%. The impetus behind this forecasted growth stems from a higher occurrence of chronic kidney disease, an escalating patient base for hypertension, elevated spending on the creation of new medicines, enhanced patient knowledge and empowerment, and government-led initiatives. Expected trends for the forecast period encompass enhanced diagnosis methods and procedures, treatment advancements, groundbreaking treatment drugs, and partnerships involving healthcare providers.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21206&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theHypercalcemia Treatment Market?
The increasing occurrence of parathyroid disorders is anticipated to stimulate the expansion of the hypercalcemia treatment market. These disorders involve the parathyroid glands, which control the body’s calcium levels by creating the parathyroid hormone (PTH). Factors such as an aging population, heightened awareness, enhanced diagnostic abilities, and increasing rates of specific conditions like primary hyperparathyroidism and chronic kidney disease contribute to this rise. The importance of hypercalcemia treatment in managing parathyroid disorders cannot be undermined as it controls high calcium levels, averts complications like kidney stones and bone loss, and helps maintain metabolic equilibrium. As per the National Institute of Health (NIH), a US governmental agency, in February 2024, hypoparathyroidism is projected to impact 6.4 to 37 per 100,000 person-years in the United States, where 75% of the cases are due to complications from thyroidectomy or head and neck surgery. Hence, the increased prevalence of parathyroid disorders is fuelling the growth of the hypercalcemia treatment market.
Which Segments in the Hypercalcemia Treatment Offer the Most Growth?
The hypercalcemia treatmentmarket covered in this report is segmented –
1) By Drug Type: Bisphosphonates; Calcitonin; Glucocorticoids; Denosumab; Calcimimetics; Other Drug Types
2) By Indication: Primary Hyperthyroidism; Hypercalcemia Of Malignancy; Other Indications
3) By Distribution Channel: Hospitals Pharmacies; Retail Pharmacies; Online Pharmacies
4) By End-Users: Hospitals; Clinics
Subsegments:
1) By Bisphosphonates: Zoledronic Acid; Pamidronate; Alendronate
2) By Calcitonin: Salmon Calcitonin; Synthetic Calcitonin
3) By Glucocorticoids: Prednisone; Dexamethasone; Hydrocortisone
4) By Denosumab: Denosumab (Monotherapy); Denosumab Combination Therapy
5) By Calcimimetics: Cinacalcet; Etelcalcetide
6) By Other Drug Types: Gallium Nitrate; Mithramycin
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21206&type=smp
What Are the Fastest-Growing Geographies in the #How Are Key Drivers in the Industry Acting as Catalysts for the Growth of theHypercalcemia Treatment Market?# Market?
North America was the largest region in the hypercalcemia treatment market in 2024. The regions covered in the hypercalcemia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Hypercalcemia Treatment Industry?
Leading corporations in the hypercalcemia treatment market are directing their efforts towards the development of ground-breaking products like phosphate binders. This is aimed at better control over the balance of calcium and phosphorus, thereby enhancing the results of the treatment. Phosphate binders, which prevent the digestion system’s absorption of phosphate into the bloodstream, are commonly prescribed to control increased phosphate levels in people with kidney diseases or hypercalcemia. For example, Strides Pharma Science Limited, a pharmaceutical company based in India, achieved FDA approval in May 2024 for its 800mg Sevelamer Carbonate Tablets. These tablets effectively regulate hyperphosphatemia in chronic kidney disease patients by binding dietary phosphate and forestalling absorption. This not only helps to maintain the health of the bone but also minimizes cardiovascular risks related to high phosphate levels.
View the full report here:
https://www.thebusinessresearchcompany.com/report/hypercalcemia-treatment-global-market-report
What Are the Key Elements That Define the Hypercalcemia Treatment Market?
Hypercalcemia treatment is the medical management of elevated calcium levels in the blood resulting from conditions such as hyperparathyroidism or malignancies. Treatment includes hydration, diuretics, bisphosphonates, or calcitonin to lower calcium levels and prevent complications. It is applied in emergency and long-term care settings to prevent kidney damage, neurological issues, and cardiac dysfunction.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21206
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model